PORTFOLIO


ELSA manages a diversified portfolio of multiple investments in the life sciences industry. In total, the portfolio contains a number of compounds in varying development stages, all of which target multi-billion-Euro markets in the life science sector. A list of current and past investments can be found below.

AEP GmbH

AEP GmbH

Glycotope GmbH

Glycotope GmbH

Myelo Therapeutics GmbH

Myelo Therapeutics GmbH

Acuros GmbH

Acuros GmbH

CC-Ery GmbH

CC-Ery GmbH

OctreoPharm Sciences GmbH

OctreoPharm Sciences GmbH

SurgicEye GmbH

SurgicEye GmbH

Pentixapharm GmbH

Eckert & Ziegler AG

Eckert & Ziegler AG

1717 Live Science Ventures

1717 Live Science Ventures

RISE Technologies GmbH

RISE Technologies GmbH

Cellsense Technologies GmbH

Avidal Vascular GmbH

Avidal Vascular GmbH

Avitop GmbH

Avitop GmbH

Viomedo UG

Viomedo UG

IUT Technologies GmbH

IUT Technologies GmbH